Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance
NCT01514942Phase 4Completed
- Sponsor
- AGUNCO Obstetrics and Gynecology Centre
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of myo-inositol, bCalm in polycystic ovary syndrome (PCOS), insulin resistance (IR), sponsored by AGUNCO Obstetrics and Gynecology Centre. Status: completed.
02
Drugs
myo-inositolbCalm
03
Conditions
polycystic ovary syndrome (PCOS)insulin resistance (IR)
Beyond the preview
Go deeper on NCT01514942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01514942.